Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ageLOC R2 Day - TGA Drug Approval Details

Approvals/TGA/ageLOC R2 Day

Approved

STANDARD

ageLOC R2 Day

Nu Skin Enterprises Australia Inc🇦🇺 Therapeutic Goods Administration

Approval Date: May 29, 2025
Approval ID: d653d7a29cdb2a36
Company: Nu Skin Enterprises Australia Inc
Type: Standard

Approval Details

Approval Id: d653d7a29cdb2a36
Product Name: ageLOC R2 Day
Artg Id: 349151
Artg Name: ageLOC R2 Day
Sponsor: Nu Skin Enterprises Australia Inc
Company Detail Path: /organization/nu-skin-enterprises-australia-inc
Artg Date: 2020-11-20
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: LI

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

d653d7a29cdb2a36

Type

Standard

Back to TGA Approvals